-transparent.png){kind=logo}
The development of anti-N-like antibodies has been demonstrated with formaldehyde reuse of hemodialyzers. It has been recommended to pursue a postrinsing venous effluent formaldehyde concentration in the range of or below 2 to 10 ppm, in order to prevent the development of these anti-N-like antibodies. In the present study, we evaluated formaldehyde reuse in a population of 50 patients and whether the strict control of predialysis effluent formaldehyde concentration below 2 to 3 ppm could prevent the development of anti-N-like antibodies. Five of 50 patients (10%) became positive 6 to 14 months after the start of formaldehyde reuse, indicating that even a careful control of effluent formaldehyde concentration cannot prevent the occurrence of this abnormality.
R Vanholder, and
L Noens, and
R De Smet, and
S Ringoir
January 1980,
Proceedings of the Clinical Dialysis and Transplant Forum,
R Vanholder, and
L Noens, and
R De Smet, and
S Ringoir
January 1981,
Clinical nephrology,
R Vanholder, and
L Noens, and
R De Smet, and
S Ringoir
July 1979,
Klinische Wochenschrift,
R Vanholder, and
L Noens, and
R De Smet, and
S Ringoir
January 1978,
Vox sanguinis,
R Vanholder, and
L Noens, and
R De Smet, and
S Ringoir
August 1977,
Lancet (London, England),
R Vanholder, and
L Noens, and
R De Smet, and
S Ringoir
January 1981,
Journal of clinical pathology,
R Vanholder, and
L Noens, and
R De Smet, and
S Ringoir
July 1977,
Kidney international,
R Vanholder, and
L Noens, and
R De Smet, and
S Ringoir
January 1977,
Transfusion,
R Vanholder, and
L Noens, and
R De Smet, and
S Ringoir
October 1993,
Sangre,
R Vanholder, and
L Noens, and
R De Smet, and
S Ringoir
November 1978,
Israel journal of medical sciences,
